Operative vs Non-operative Management of Posterior-medial Meniscal Root Tears: A Randomized Multicenter Trial (RCT)

NARecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

April 20, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

March 31, 2028

Conditions
Meniscus Tear, Tibial
Interventions
OTHER

Non-Operative Pain Management

The non-operative treatment arm will receive analgesics, physical therapy and will remain non-weight bearing. This will consist in anti-inflammatory drugs daily for 8-12 weeks and supervised physical therapy at least twice a week over a period of 8 weeks. Subjects in the non-operative arm will be offered the opportunity to crossover to the operative arm (ARM 2) of the study if the subjects do not report symptomatic improvement within 3 months after entry in this study.

PROCEDURE

Operative treatment arm will undergo transtibial medial meniscus root repair within 3 weeks of enrollment

The operative treatment group (ARM 2) will be treated acutely with a transtibial medial meniscus root repair and will be non-weight bearing for 6 weeks as well. For ARM 1 subjects if no subjective improvement is seen at 3 months, crossover will be allowed to a transtibial medial meniscal root repair (acute operative pathway (ARM 2)

Trial Locations (1)

60612

RECRUITING

Rush University Medical Center, Chicago

All Listed Sponsors
collaborator

International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine (ISAKOS)

UNKNOWN

lead

Rush University Medical Center

OTHER